daunorubicin has been researched along with rutin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maser, E; Soldan, M | 1 |
Iffert, T; Maser, E; Moeller, A; Soldan, M | 1 |
Kang, W; Weiss, M | 1 |
Blanco, JG; Ghosh, D; Gonzalez-Covarrubias, V; Lakhman, SS; Pendyala, L | 1 |
Blanco, JG; Gonzalez-Covarrubias, V; Kalabus, JL | 1 |
Carlquist, M; Frejd, T; Gorwa-Grauslund, MF | 1 |
Blanco, JG; Cheng, Q; Ferguson, DC | 1 |
7 other study(ies) available for daunorubicin and rutin
Article | Year |
---|---|
Metabolic inactivation and efflux of daunorubicin as complementary mechanisms in tumor cell resistance.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoenzymes; Models, Biological; Oxidoreductases; Pancreatic Neoplasms; Quercetin; Rutin; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Modulation of daunorubicin toxicity by liposomal encapsulation and use of specific inhibitors in vitro.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Drug Carriers; Drug Compounding; Drug Resistance, Neoplasm; Humans; Liposomes; Rutin; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Modeling the metabolism of idarubicin to idarubicinol in rat heart: effect of rutin and phenobarbital.
Topics: Amiodarone; Animals; Antineoplastic Agents; Daunorubicin; Drug Design; Excitatory Amino Acid Antagonists; Heart; Idarubicin; Kinetics; Male; Phenobarbital; Rats; Rats, Sprague-Dawley; Rutin; Time Factors; Vasodilator Agents; Verapamil | 2003 |
A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity.
Topics: Alcohol Oxidoreductases; Catalysis; Cloning, Molecular; Daunorubicin; DNA, Complementary; Genotype; Humans; Kinetics; Models, Molecular; NADP; Polymorphism, Single Nucleotide; Rutin; Sequence Analysis, DNA | 2007 |
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER).
Topics: Alcohol Oxidoreductases; Antibiotics, Antineoplastic; Cardiotonic Agents; Data Interpretation, Statistical; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Genotype; Humans; Hydroxyethylrutoside; Kinetics; Recombinant Proteins | 2008 |
Flavonoids as inhibitors of human carbonyl reductase 1.
Topics: Alcohol Oxidoreductases; Antibiotics, Antineoplastic; Binding Sites; Daunorubicin; Enzyme Inhibitors; Flavonoids; Gene Expression; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Plant Extracts; Polymerase Chain Reaction; Protein Structure, Tertiary; Quercetin; Rutin; Saccharomyces cerevisiae; Substrate Specificity; Transfection | 2008 |
Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
Topics: Alcohol Oxidoreductases; Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cloning, Molecular; Daunorubicin; DNA, Complementary; Dogs; Dose-Response Relationship, Drug; Escherichia coli; Humans; Isoenzymes; Kinetics; Male; Oxidation-Reduction; Polymorphism, Single Nucleotide; Recombinant Proteins; Rutin; Vitamin K 3 | 2015 |